Cryptococcal meningitis

L Tugume, K Ssebambulidde, J Kasibante… - Nature Reviews …, 2023 - nature.com
Cryptococcus neoformans and Cryptococcus gattii species complexes cause
meningoencephalitis with high fatality rates and considerable morbidity, particularly in …

Tuberculosis and HIV co-infection

A Pawlowski, M Jansson, M Sköld… - PLoS …, 2012 - journals.plos.org
Tuberculosis (TB) and HIV co-infections place an immense burden on health care systems
and pose particular diagnostic and therapeutic challenges. Infection with HIV is the most …

A trial of early antiretrovirals and isoniazid preventive therapy in Africa

Temprano ANRS 12136 Study … - New England Journal of …, 2015 - Mass Medical Soc
Background In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)–
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …

Systemic effects of inflammation on health during chronic HIV infection

SG Deeks, R Tracy, DC Douek - Immunity, 2013 - cell.com
Combination antiretroviral therapy for HIV infection improves immune function and
eliminates the risk of AIDS-related complications but does not restore full health. HIV …

HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased …

S Serrano-Villar, T Sainz, SA Lee, PW Hunt… - PLoS …, 2014 - journals.plos.org
A low CD4/CD8 ratio in elderly HIV-uninfected adults is associated with increased morbidity
and mortality. A subset of HIV-infected adults receiving effective antiretroviral therapy (ART) …

Soluble markers of inflammation and coagulation but not T-cell activation predict non–AIDS-defining morbid events during suppressive antiretroviral treatment

AR Tenorio, Y Zheng, RJ Bosch… - The Journal of …, 2014 - academic.oup.com
Background. Defining the association of non–AIDS-defining events with inflammation and
immune activation among human immunodeficiency virus (HIV)–infected persons with …

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection

PW Hunt, E Sinclair, B Rodriguez… - The Journal of …, 2014 - academic.oup.com
Background. While inflammation predicts mortality in treated human immunodeficiency virus
(HIV) infection, the prognostic significance of gut barrier dysfunction and phenotypic T-cell …

Defective HIV-1 proviruses produce viral proteins

H Imamichi, M Smith, JW Adelsberger… - Proceedings of the …, 2020 - National Acad Sciences
HIV-1 proviruses persist in the CD4+ T cells of HIV-infected individuals despite years of
combination antiretroviral therapy (cART) with suppression of HIV-1 RNA levels< 40 …

Immune activation and HIV persistence: implications for curative approaches to HIV infection

NR Klatt, N Chomont, DC Douek… - Immunological …, 2013 - Wiley Online Library
Despite complete or near‐complete suppression of human immunodeficiency virus (HIV)
replication with combination antiretroviral therapy, both HIV and chronic …

[HTML][HTML] Editor's choice: persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection

I Sereti, SJ Krebs, N Phanuphak… - … diseases: an official …, 2017 - ncbi.nlm.nih.gov
Background. Serious non-AIDS events cause substantial disease and death despite human
immunodeficiency virus (HIV) suppression with antiretroviral therapy (ART). Biomarkers of …